JPMorgan Chase & Co’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-124
| Closed | -$377 | – | 6782 |
|
|
2023
Q4 | $377 | Sell |
124
-372
| -75% | -$1.13K | ﹤0.01% | 5923 |
|
|
2023
Q3 | $1.41K | Hold |
496
| – | – | ﹤0.01% | 5639 |
|
|
2023
Q2 | $1.29K | Hold |
496
| – | – | ﹤0.01% | 5514 |
|
|
2023
Q1 | $1K | Hold |
496
| – | – | ﹤0.01% | 5709 |
|
|
2022
Q4 | $1K | Sell |
496
-1,536
| -76% | -$3.1K | ﹤0.01% | 5511 |
|
|
2022
Q3 | $4K | Buy |
2,032
+614
| +43% | +$1.21K | ﹤0.01% | 5255 |
|
|
2022
Q2 | $4K | Sell |
1,418
-11,519
| -89% | -$32.5K | ﹤0.01% | 5356 |
|
|
2022
Q1 | $49K | Buy |
12,937
+6,616
| +105% | +$25.1K | ﹤0.01% | 5021 |
|
|
2021
Q4 | $71K | Buy |
6,321
+1,903
| +43% | +$21.4K | ﹤0.01% | 4951 |
|
|
2021
Q3 | $77K | Buy |
+4,418
| New | +$77K | ﹤0.01% | 4829 |
|